{
     "PMID": "10319819",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19990520",
     "LR": "20131121",
     "IS": "0092-8674 (Print) 0092-8674 (Linking)",
     "VI": "97",
     "IP": "3",
     "DP": "1999 Apr 30",
     "TI": "Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation.",
     "PG": "395-406",
     "AB": "The amyloid-beta precursor protein (APP) is directly and efficiently cleaved by caspases during apoptosis, resulting in elevated amyloid-beta (A beta) peptide formation. The predominant site of caspase-mediated proteolysis is within the cytoplasmic tail of APP, and cleavage at this site occurs in hippocampal neurons in vivo following acute excitotoxic or ischemic brain injury. Caspase-3 is the predominant caspase involved in APP cleavage, consistent with its marked elevation in dying neurons of Alzheimer's disease brains and colocalization of its APP cleavage product with A beta in senile plaques. Caspases thus appear to play a dual role in proteolytic processing of APP and the resulting propensity for A beta peptide formation, as well as in the ultimate apoptotic death of neurons in Alzheimer's disease.",
     "FAU": [
          "Gervais, F G",
          "Xu, D",
          "Robertson, G S",
          "Vaillancourt, J P",
          "Zhu, Y",
          "Huang, J",
          "LeBlanc, A",
          "Smith, D",
          "Rigby, M",
          "Shearman, M S",
          "Clarke, E E",
          "Zheng, H",
          "Van Der Ploeg, L H",
          "Ruffolo, S C",
          "Thornberry, N A",
          "Xanthoudakis, S",
          "Zamboni, R J",
          "Roy, S",
          "Nicholson, D W"
     ],
     "AU": [
          "Gervais FG",
          "Xu D",
          "Robertson GS",
          "Vaillancourt JP",
          "Zhu Y",
          "Huang J",
          "LeBlanc A",
          "Smith D",
          "Rigby M",
          "Shearman MS",
          "Clarke EE",
          "Zheng H",
          "Van Der Ploeg LH",
          "Ruffolo SC",
          "Thornberry NA",
          "Xanthoudakis S",
          "Zamboni RJ",
          "Roy S",
          "Nicholson DW"
     ],
     "AD": "Department of Pharmacology, Biochemistry, and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Merck Research Laboratories, Kirkland, Quebec, Canada.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Cell",
     "JT": "Cell",
     "JID": "0413066",
     "RN": [
          "0 (Amyloid beta-Peptides)",
          "0 (Amyloid beta-Protein Precursor)",
          "0 (Cysteine Proteinase Inhibitors)",
          "0 (Enzyme Inhibitors)",
          "0 (Enzyme Precursors)",
          "0 (Excitatory Amino Acid Agonists)",
          "0 (Oligopeptides)",
          "0 (acetyl-aspartyl-glutamyl-valyl-aspartal)",
          "143313-51-3 (L 709049)",
          "30KYC7MIAI (Aspartic Acid)",
          "EC 3.4.- (Amyloid Precursor Protein Secretases)",
          "EC 3.4.- (Endopeptidases)",
          "EC 3.4.22.- (CASP3 protein, human)",
          "EC 3.4.22.- (Casp3 protein, mouse)",
          "EC 3.4.22.- (Casp3 protein, rat)",
          "EC 3.4.22.- (Caspase 3)",
          "EC 3.4.22.- (Caspases)",
          "EC 3.4.23.- (Aspartic Acid Endopeptidases)",
          "EC 3.4.23.46 (BACE1 protein, human)",
          "EC 3.4.23.46 (Bace1 protein, mouse)",
          "SIV03811UC (Kainic Acid)",
          "XT3Z54Z28A (Camptothecin)"
     ],
     "SB": "IM",
     "MH": [
          "Acute Disease",
          "Alzheimer Disease/*enzymology/genetics/pathology",
          "Amyloid Precursor Protein Secretases",
          "Amyloid beta-Peptides/genetics/*metabolism",
          "Amyloid beta-Protein Precursor/genetics/*metabolism",
          "Amyloidosis/*enzymology/genetics/pathology",
          "Animals",
          "Apoptosis/drug effects/genetics",
          "Aspartic Acid",
          "Aspartic Acid Endopeptidases",
          "Brain Diseases/chemically induced/enzymology/pathology",
          "Camptothecin/pharmacology",
          "Caspase 3",
          "Caspases/analysis/*metabolism",
          "Cysteine Proteinase Inhibitors/pharmacology",
          "Endopeptidases/genetics",
          "Enzyme Inhibitors/pharmacology",
          "Enzyme Precursors/analysis/metabolism",
          "Excitatory Amino Acid Agonists",
          "Hippocampus/cytology",
          "Humans",
          "In Situ Nick-End Labeling",
          "Kainic Acid",
          "Leukemia, Erythroblastic, Acute",
          "Male",
          "Mice",
          "Mice, Inbred C57BL",
          "Mutation/physiology",
          "Neurons/chemistry/cytology/enzymology",
          "Oligopeptides/pharmacology",
          "Rabbits",
          "Rats",
          "Rats, Wistar",
          "Sweden",
          "Tumor Cells, Cultured"
     ],
     "EDAT": "1999/05/13 00:00",
     "MHDA": "1999/05/13 00:01",
     "CRDT": [
          "1999/05/13 00:00"
     ],
     "PHST": [
          "1999/05/13 00:00 [pubmed]",
          "1999/05/13 00:01 [medline]",
          "1999/05/13 00:00 [entrez]"
     ],
     "AID": [
          "S0092-8674(00)80748-5 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Cell. 1999 Apr 30;97(3):395-406.",
     "term": "hippocampus"
}